Skip to main content
PMC home page
Occupational and Environmental Medicine logoLink to Occupational and Environmental Medicine
. 2000 Feb;57(2):106–115. doi: 10.1136/oem.57.2.106

A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-β-naphthylamine and o-toluidine

T Sorahan 1, L Hamilton 1, J Jackson 1
PMCID: PMC1739914  PMID: 10711278

Abstract

OBJECTIVES—To investigate mortality and cancer morbidity in workers from a factory manufacturing chemicals for the rubber industry.
METHODS—The mortality (1955-96) and cancer morbidity experience (1971-92) of a cohort of 2160 male production workers from a chemical factory in north Wales were investigated. All subjects had at least 6 months employment at the factory and some employment in the period 1955-84. Detailed job histories were abstracted from company computerised records and estimates of individual cumulative exposure to 2-mercaptobenzothiazole (MBT) and its derivatives were obtained, with a job exposure matrix derived by a former factory hygienist. Durations of employment in the aniline, phenyl-β-naphthylamine (PBN) and o-toluidine departments were also calculated. Two analytical approaches were used, indirect standardisation and Poisson regression.
RESULTS—Based on serial rates for the general population of England and Wales, observed mortality for the total cohort was close to expectation for all causes (observed (obs) deaths 1131, expected (exp) deaths 1114.5, standardised mortality ratio (SMR) 101), and for all cancers (obs 305, exp 300.2, SMR 102). There was a significant (p<0.05) excess mortality from cancer of the bladder in the 605 study subjects potentially exposed to one or more of the four chemicals being investigated (obs 9, exp 3.25, SMR 277, 95% confidence interval (95% CI) 127 to 526). This excess was dependent primarily on deaths occurring >20 years after first exposure in those who started employment before 1955 (obs 7, exp 1.25, SMR 560, 95% CI 225 to 1154, p<0.001). There were 30 subjects in the total study cohort who, on the basis of death certificates or cancer registration particulars, had had malignant bladder cancer. In separate analyses of the four exposure history variables (after adjustment for age), Poisson regression showed significant positive trends for risk of notification of bladder cancer increasing with cumulative duration of employment in the PBN (p<0.001) and o-toluidine departments (p<0.01); similar findings were not obtained for cumulative exposure to MBT or for duration of employment in the aniline department. In a simultaneous analysis of all four chemical exposure variables, a significant positive trend remained for duration of employment with exposure to PBN (p<0.05). Further analyses of all cases of bladder cancer (malignant and benign diagnoses) used employment histories lagged by 15 years; similar findings were obtained.
CONCLUSIONS—It seems likely that some members of this cohort have had occupational bladder cancer. Confident interpretation is difficult because of small numbers in the exposed subcohorts, relatively crude measures of exposure assessment for the four chemicals under study, and presence of unconsidered potential chemical confounders. The simplest interpretation of the findings about bladder cancer may be that PBN (or a chemical reagent or chemical intermediate associated with its production at this factory in the 1930s and 1940s) is a bladder carcinogen. Priority should be given, however, to obtaining information on the cancer experience of other working populations exposed to PBN or to o-toluidine.


Keywords: 2-mercaptobenzothiazole; phenyl-β-naphthylamine; o-toluidine; aniline

Full Text

The Full Text of this article is available as a PDF (182.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acquavella J. F., Wilson J. D., Conner P., Bannister R. An alternative hypothesis for bladder cancer among workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst. 1991 Nov 20;83(22):1686–1687. doi: 10.1093/jnci/83.22.1686. [DOI] [PubMed] [Google Scholar]
  2. Acquavella J. F., Wilson J. D., Conner P., Bannister R. An alternative hypothesis for bladder cancer among workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst. 1991 Nov 20;83(22):1686–1687. doi: 10.1093/jnci/83.22.1686. [DOI] [PubMed] [Google Scholar]
  3. Anderson M. M., Mitchum R. K., Beland F. A. Hepatic microsomal metabolism and macromolecular binding of the antioxidant, N-phenyl-2-naphthylamine. Xenobiotica. 1982 Jan;12(1):31–43. doi: 10.3109/00498258209052452. [DOI] [PubMed] [Google Scholar]
  4. Coleman M., Douglas A., Hermon C., Peto J. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol. 1986 Mar;15(1):134–137. doi: 10.1093/ije/15.1.134. [DOI] [PubMed] [Google Scholar]
  5. Green U., Holste J., Spikermann A. R. A comparative study of the chronic effects of magenta, paramagenta, and phenyl-beta-naphthylamine in Syrian golden hamsters. J Cancer Res Clin Oncol. 1979 Sep;95(1):51–55. doi: 10.1007/BF00411109. [DOI] [PubMed] [Google Scholar]
  6. Ketkar M. B., Mohr U. The chronic effects of magenta, paramagenta and phenyl-beta-naphthylamine in rats after intragastric administration. Cancer Lett. 1982 Jul-Aug;16(2):203–206. doi: 10.1016/0304-3835(82)90062-3. [DOI] [PubMed] [Google Scholar]
  7. Laham S., Potvin M. Biological conversion of N-phenyl-2-naphthylamine to 2-naphthylamine in the Sprague-Dawley rat. Drug Chem Toxicol. 1983;6(3):295–309. doi: 10.3109/01480548309017820. [DOI] [PubMed] [Google Scholar]
  8. Melick W. F., Naryka J. J., Kelly R. E. Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup. J Urol. 1971 Aug;106(2):220–226. doi: 10.1016/s0022-5347(17)61263-1. [DOI] [PubMed] [Google Scholar]
  9. Sellers C., Markowitz S. Reevaluating the carcinogenicity of ortho-toluidine: a new conclusion and its implications. Regul Toxicol Pharmacol. 1992 Dec;16(3):301–317. doi: 10.1016/0273-2300(92)90010-7. [DOI] [PubMed] [Google Scholar]
  10. Sorahan T., Lancashire R. J., Sole G. Urothelial cancer and cigarette smoking: findings from a regional case-controlled study. Br J Urol. 1994 Dec;74(6):753–756. doi: 10.1111/j.1464-410x.1994.tb07120.x. [DOI] [PubMed] [Google Scholar]
  11. Sorahan T., Pope D. Mortality study of workers employed at a plant manufacturing chemicals for the rubber industry: 1955-86. Br J Ind Med. 1993 Nov;50(11):998–1002. doi: 10.1136/oem.50.11.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Strauss M. E., Barrick E. D., Bannister R. M. Mortality experience of employees exposed to 2-mercaptobenzothiazole at a chemical plant in Nitro, West Virginia. Br J Ind Med. 1993 Oct;50(10):888–893. doi: 10.1136/oem.50.10.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ward E., Carpenter A., Markowitz S., Roberts D., Halperin W. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst. 1991 Apr 3;83(7):501–506. doi: 10.1093/jnci/83.7.501. [DOI] [PubMed] [Google Scholar]

Articles from Occupational and Environmental Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES